Hematoma-inspired alginate/platelet releasate/CaPO4 composite: Initiation of the inflammatory-mediated response associated with fracture repair in vitro and ex vivo injection delivery

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 8, 2012, Pages 1971-1981

  McCanless, Jonathan D ^a   Jennings, Lisa K ^b,c   Bumgardner, Joel D ^a   Cole, Judith A ^d   Haggard, Warren O ^a  

^a University of Memphis   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d University of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIO-COMPOSITES; BONE FORMATION; BONE REGENERATION; BONE REMODELING; CELL LINES; EX-VIVO; FRACTURE REPAIR; IN-VITRO; INFLAMMATORY RESPONSE; OSSEOUS TISSUE; OSTEOCONDUCTIVE; WOUND HEALING;

BIOMATERIALS; BONE; CELL CULTURE; SCAFFOLDS (BIOLOGY); TISSUE;

FRACTURE;

ALGINIC ACID; BIOACTIVE CONCENTRATED HUMAN PLATELET RELEASATE; BIOMATERIAL; CALCIUM PHOSPHATE; GROWTH FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AVASCULAR NECROSIS; BIOSYNTHESIS; BONE REGENERATION; BONE REMODELING; CHEMICAL COMPOSITION; COMPOSITE MATERIAL; CONTROLLED STUDY; EX VIVO STUDY; FRACTURE HEALING; FRACTURE NONUNION; GENE EXPRESSION REGULATION; HEMATOMA; HUMAN; HYDROGEL; IMPLANTATION; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR INTERACTION; MONOCYTE; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; VERTEBRA BODY;

ALGINATES; ANIMALS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CELL LINE; DELAYED-ACTION PREPARATIONS; FRACTURES, BONE; GLUCURONIC ACID; HEMATOMA; HEXURONIC ACIDS; HUMANS; INJECTIONS; MICE; MICE, INBRED BALB C; MONOCYTES; PLATELET TRANSFUSION; RATS;

EID: 84864955628     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4672-9     Document Type: Article

References (43)

1. Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future directions. BMC Med. 2011;9 (66):1-10.
2. Bauer TW. An overview of the histology of skeletal substitute materials. Arch Pathol Lab Med. 2007;131 (2):217-24.
3. Kolk A, Handschel J, Drescher W, Rothamel D, Kloss F, Blessmann M, et al. Current trends and future perspectives of bone substitute materials-from space holders to innovative biomaterials. J Craniomaxillofac Surg. 2012. [Epub ahead of print].
4. Janicki P, Schmidmaier G. What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury. 2011;42 (Suppl 2):S77-81.
5. Kalfas IH. Principles of bone healing. Neurosurg Focus. 2001;10 (4);E1:1-4.
6. Kolar P, Schmidt-Bleek K, Schell H, Gaber T, Toben D, Schmidmaier G, et al. The early fracture hematoma and its potential role in fracture healing. Tissue Eng B. 2010;16 (4): 427-34.
7. Sun Y, Feng Y, Zhang CQ, Chen SB, Cheng XG. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop. 2010;34 (4):589-97.
8. Burg KJ, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials. 2000;21 (23):2347-59.
9. Williams DF. On the mechanisms of biocompatibility. Biomaterials. 2008;29 (20):2941-53.
10. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, et al. Platelet-rich plasma: growth factors and pro-and antiinflammatory properties. J Periodontol. 2007;78 (4):661-9.
11. Mehta S, Watson JT. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma. 2008;22 (6):432-8.
12. McCanless JD, Jennings LK, Cole JA, Bumgardner JD, Haggard WO. In vitro differentiation and biocompatibility of mesenchymal stem cells on a novel platelet releasate-containing injectable composite. J Biomed Mater Res A. 2012;100 (1):220-9.
13. McCanless JD, Jennings LK, Cole JA, Bumgardner JD, Haggard WO. Induction of the early inflammatory-mediated cellular responses of fracture healing in vitro using platelet releasatecontaining alginate/CaPO4 biomaterials for early osteoarthritis prevention. J Biomed Mater Res A. 2012;100 (5):1107-14.
14. Haggard WO, McCanless JD, Inventors; University of Memphis, Assignee. Provisional patent application: Biomaterial composition and method of use, 6 May 2011.
15. Beamer B, Hettrich C, Lane J. Vascular endothelial growth factor: an essential component of angiogenesis and fracture healing. HSS J. 2010;6 (1):85-94.
16. Ma PX. Alginate for tissue engineering. In: Ma PX, Elisseeff J, editors. Scaffolding in tissue engineering. Boca Raton: CRC Press; 2006. p. 13-25.
17. Nunamaker EA, Purcell EK, Kipke DR. In vivo stability and biocompatibility of implanted calcium alginate disks. J Biomed Mater Res A. 2007;83 (4):1128-37.
18. Kong H, Mooney DJ. Polysaccharide-based hydrogels in tissue engineering. In: Dumitriu S, editor. Polysaccharides: structural diversity and functional versatility. 2nd ed. New York: CCR Press; 2005. p. 817-38.
19. White MM, Jennings LK. Appendix. Platelet protocols: research and clinical laboratory procedures. San Diego: Academic Press; 1999. p. 99-101.
20. Nicolin V, Ponti C, Narducci P, Grill V, Bortul R, Zweyer M, et al. Different levels of the neuronal nitric oxide synthase isoform modulate the rate of osteoclastic differentiation of TIB-71 and CRL-2278 RAW 264.7 murine cell clones. Anat Rec A. 2005;286 (2):945-54.
21. Lock EF, Ziemiecke R, Marron J, Dittmer DP. Efficiency clustering for low-density microarrays and its application to QPCR. BMC Bioinform. 2010;11 (386):1-8.
22. McCanless J, Cole J, Jennings L, Bumgardner J, Haggard W, editors. Biomaterial-assessed fracture healing as a model for the early prevention of joint degeneration: in vitro osteochondrogenesis, angiogenesis, immune response, and ex vivo injection delivery (in review). 58th Annual Meeting of the Orthopaedic Research Society, San Franscisco, CA; 2012.
23. Goldring SR. The role of bone in osteoarthritis pathogenesis. Rheum Dis Clin N Am. 2008;34 (3):561-71.
24. Motamedi K, Seeger LL. Benign bone tumors. Radiol Clin N Am. 2011;49 (6):1115-34, v.
25. Schmidhammer R, Zandieh S, Mittermayr R, Pelinka LE, Leixnering M, Hopf R, et al. Assessment of bone union/nonunion in an experimental model using microcomputed technology. J Trauma. 2006;61 (1):199-205.
26. Mora R, Paley D. Nonunion of the long bones: diagnosis and treatment with compression-distraction techniques. New York: Springer; 2006.
27. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423 (6937):337-42.
28. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5 (12):953-64.
29. Tanaka T, Saito M, Chazono M, Kumagae Y, Kikuchi T, Kitasato S, et al. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate. J Biomed Mater Res. 2010;93 (2):469-74.
30. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011;11 (4):264-74.
31. Brass L. Understanding and evaluating platelet function. Hematol Am Soc Hematol Educ Program. 2010;2010:387-96.
32. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science (New York, NY). 2010;328 (5978):562-4.
33. dos Santos EA, Farina M, Soares GA, Anselme K. Surface energy of hydroxyapatite and beta-tricalcium phosphate ceramics driving serum protein adsorption and osteoblast adhesion. J Mater Sci Mater Med. 2008;19 (6):2307-16.
34. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood. 2006;107 (2):637-41.
35. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, et al. Expression of Toll-like receptors on human platelets. Thromb Res. 2004;113 (6):379-85.
36. Haselmayer P, Grosse-Hovest L, von Landenberg P, Schild H, Radsak MP. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood. 2007;110 (3):1029-35.
37. Washington AV, Gibot S, Acevedo I, Gattis J, Quigley L, Feltz R, et al. TREM-like transcript-1 protects against inflammationassociated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Investig. 2009;119 (6):1489-501.
38. Mitani T, Terashima M, Yoshimura H, Nariai Y, Tanigawa Y. TGF-beta1 enhances degradation of IFN-gamma-induced iNOS protein via proteasomes in RAW 264.7 cells. Nitric Oxide. 2005;13 (1):78-87.
39. Gruber R, Karreth F, Fischer MB, Watzek G. Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL- dependent mechanism. Bone. 2002;30 (5): 726-32.
40. Cuetara BL, Crotti TN, O'Donoghue AJ, McHugh KP. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line. In Vitro Cell Dev Biol Anim. 2006;42 (7):182-8.
41. Gurevitch O, Slavin S, Resnick I, Khitrin S, Feldman A. Mesenchymal progenitor cells in red and yellow bone marrow. Folia Biol (Praha). 2009;55 (1):27-34.
42. Muguruma Y, Yahata T, Miyatake H, Sato T, Uno T, Itoh J, et al. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood. 2006;107 (5):1878-87.
43. Wang ML, Massie J, Perry A, Garfin SR, Kim CW. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements. Spine J. 2007;7 (4):466-74.